The VEGF-A/VEGFR-2 signaling pathway reportedly functions as the main axis of driving angiogenesis under physiological and pathological conditions [25], which inspired the development of VEGFR-2 inhibitors as alternative drug candidates for neovascular AMD [26,27,28] or retinopathy [29]. Here, KDR is linked to retinal disorder.